• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全基因组关联和连锁分析确定了囊性纤维化肺疾病严重程度的修饰基因座,位于 11p13 和 20q13.2。

Genome-wide association and linkage identify modifier loci of lung disease severity in cystic fibrosis at 11p13 and 20q13.2.

机构信息

Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

出版信息

Nat Genet. 2011 Jun;43(6):539-46. doi: 10.1038/ng.838. Epub 2011 May 22.

DOI:10.1038/ng.838
PMID:21602797
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3296486/
Abstract

A combined genome-wide association and linkage study was used to identify loci causing variation in cystic fibrosis lung disease severity. We identified a significant association (P = 3.34 × 10(-8)) near EHF and APIP (chr11p13) in p.Phe508del homozygotes (n = 1,978). The association replicated in p.Phe508del homozygotes (P = 0.006) from a separate family based study (n = 557), with P = 1.49 × 10(-9) for the three-study joint meta-analysis. Linkage analysis of 486 sibling pairs from the family based study identified a significant quantitative trait locus on chromosome 20q13.2 (log(10) odds = 5.03). Our findings provide insight into the causes of variation in lung disease severity in cystic fibrosis and suggest new therapeutic targets for this life-limiting disorder.

摘要

一项联合全基因组关联和连锁研究用于鉴定导致囊性纤维化肺病严重程度变化的基因座。我们在 p.Phe508del 纯合子中发现了 EHF 和 APIP(chr11p13)附近的显著关联(P = 3.34×10(-8))(n = 1978)。该关联在来自独立家族研究的 p.Phe508del 纯合子中得到了复制(P = 0.006)(n = 557),三研究联合荟萃分析的 P 值为 1.49×10(-9)。来自基于家族的研究的 486 对同胞对的连锁分析确定了染色体 20q13.2 上的一个显著数量性状基因座(log(10)odds = 5.03)。我们的发现深入了解了囊性纤维化肺病严重程度变化的原因,并为这种限制生命的疾病提供了新的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1335/3296486/9d33c4b861f8/nihms291279f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1335/3296486/27ef76df3a01/nihms291279f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1335/3296486/44fee03944eb/nihms291279f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1335/3296486/b0689727f014/nihms291279f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1335/3296486/ddac1c846628/nihms291279f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1335/3296486/9d33c4b861f8/nihms291279f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1335/3296486/27ef76df3a01/nihms291279f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1335/3296486/44fee03944eb/nihms291279f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1335/3296486/b0689727f014/nihms291279f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1335/3296486/ddac1c846628/nihms291279f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1335/3296486/9d33c4b861f8/nihms291279f5.jpg

相似文献

1
Genome-wide association and linkage identify modifier loci of lung disease severity in cystic fibrosis at 11p13 and 20q13.2.全基因组关联和连锁分析确定了囊性纤维化肺疾病严重程度的修饰基因座,位于 11p13 和 20q13.2。
Nat Genet. 2011 Jun;43(6):539-46. doi: 10.1038/ng.838. Epub 2011 May 22.
2
Airway Mucosal Host Defense Is Key to Genomic Regulation of Cystic Fibrosis Lung Disease Severity.气道黏膜宿主防御是囊性纤维化肺病严重程度的基因组调控的关键。
Am J Respir Crit Care Med. 2018 Jan 1;197(1):79-93. doi: 10.1164/rccm.201701-0134OC.
3
Regulatory dynamics of 11p13 suggest a role for EHF in modifying CF lung disease severity.11p13的调控动态表明EHF在改变囊性纤维化肺病严重程度方面发挥作用。
Nucleic Acids Res. 2017 Sep 6;45(15):8773-8784. doi: 10.1093/nar/gkx482.
4
Genome-wide association meta-analysis identifies five modifier loci of lung disease severity in cystic fibrosis.全基因组关联荟萃分析确定了囊性纤维化肺病严重程度的五个修饰位点。
Nat Commun. 2015 Sep 29;6:8382. doi: 10.1038/ncomms9382.
5
Genetic association and transcriptome integration identify contributing genes and tissues at cystic fibrosis modifier loci.遗传关联和转录组整合鉴定囊性纤维化修饰基因座的贡献基因和组织。
PLoS Genet. 2019 Feb 26;15(2):e1008007. doi: 10.1371/journal.pgen.1008007. eCollection 2019 Feb.
6
The CF-modifying gene EHF promotes p.Phe508del-CFTR residual function by altering protein glycosylation and trafficking in epithelial cells.CF修饰基因EHF通过改变上皮细胞中的蛋白质糖基化和转运来促进p.Phe508del-CFTR残余功能。
Eur J Hum Genet. 2014 May;22(5):660-6. doi: 10.1038/ejhg.2013.209. Epub 2013 Oct 9.
7
Genetic Modifiers of Cystic Fibrosis Lung Disease Severity: Whole-Genome Analysis of 7,840 Patients.囊性纤维化肺病严重程度的遗传修饰物:7840 例患者的全基因组分析。
Am J Respir Crit Care Med. 2023 May 15;207(10):1324-1333. doi: 10.1164/rccm.202209-1653OC.
8
Relative contribution of genetic and nongenetic modifiers to intestinal obstruction in cystic fibrosis.基因修饰因子和非基因修饰因子对囊性纤维化患者肠梗阻的相对作用。
Gastroenterology. 2006 Oct;131(4):1030-9. doi: 10.1053/j.gastro.2006.07.016. Epub 2006 Jul 24.
9
New modifier loci in cystic fibrosis.囊性纤维化中的新修饰基因座。
Nat Genet. 2011 Jun;43(6):508-9. doi: 10.1038/ng.844.
10
The influence of genetics on cystic fibrosis phenotypes.遗传对囊性纤维化表型的影响。
Cold Spring Harb Perspect Med. 2012 Dec 1;2(12):a009548. doi: 10.1101/cshperspect.a009548.

引用本文的文献

1
Genotype and transcript processing of the tumour necrosis factor receptor TNFRSF1A in epithelial cells: implications for survival in cystic fibrosis.上皮细胞中肿瘤坏死因子受体TNFRSF1A的基因型与转录本加工:对囊性纤维化生存的影响
EBioMedicine. 2025 Jul 10;118:105848. doi: 10.1016/j.ebiom.2025.105848.
2
mTOR pathway diseases: challenges and opportunities from bench to bedside and the mTOR node.mTOR信号通路疾病:从实验室到临床的挑战与机遇以及mTOR节点
Orphanet J Rare Dis. 2025 May 27;20(1):256. doi: 10.1186/s13023-025-03740-1.
3
Impact of Gene Modifiers on Cystic Fibrosis Phenotypic Profiles: A Systematic Review.

本文引用的文献

1
A novel lung disease phenotype adjusted for mortality attrition for cystic fibrosis genetic modifier studies.一种针对囊性纤维化遗传修饰物研究进行了死亡率衰减调整的新型肺病表型。
Pediatr Pulmonol. 2011 Sep;46(9):857-69. doi: 10.1002/ppul.21456. Epub 2011 Apr 1.
2
Modifier genes in Mendelian disorders: the example of cystic fibrosis.孟德尔疾病中的修饰基因:囊性纤维化为例。
Ann N Y Acad Sci. 2010 Dec;1214:57-69. doi: 10.1111/j.1749-6632.2010.05879.x.
3
Impact of mannose-binding lectin insufficiency on the course of cystic fibrosis: A review and meta-analysis.
基因修饰因子对囊性纤维化表型谱的影响:一项系统综述。
Hum Mutat. 2024 Oct 16;2024:6165547. doi: 10.1155/2024/6165547. eCollection 2024.
4
Recent developments in cystic fibrosis drug discovery: where are we today?囊性纤维化药物研发的最新进展:我们如今处于什么阶段?
Expert Opin Drug Discov. 2025 May;20(5):659-682. doi: 10.1080/17460441.2025.2490250. Epub 2025 Apr 13.
5
Reconsidering the Diagnosis: Abnormal Sweat Chloride Tests in Non-CF Bronchiectasis.重新审视诊断:非囊性纤维化支气管扩张症中异常的汗液氯化物检测
Pediatr Pulmonol. 2025 Jan;60(1):e27471. doi: 10.1002/ppul.27471. Epub 2025 Jan 7.
6
A New Frontier in Cystic Fibrosis Pathophysiology: How and When Clock Genes Can Affect the Inflammatory/Immune Response in a Genetic Disease Model.囊性纤维化病理生理学的新前沿:生物钟基因如何以及何时会在一种遗传疾病模型中影响炎症/免疫反应。
Curr Issues Mol Biol. 2024 Sep 18;46(9):10396-10410. doi: 10.3390/cimb46090618.
7
Cell type-specific expression of angiotensin receptors in the human lung with implications for health, aging, and chronic disease.血管紧张素受体在人肺中的细胞类型特异性表达及其对健康、衰老和慢性疾病的影响。
bioRxiv. 2024 Jun 22:2024.06.17.599425. doi: 10.1101/2024.06.17.599425.
8
Systems serology in cystic fibrosis: Anti-Pseudomonas IgG1 responses and reduced lung function.囊性纤维化的系统血清学:抗铜绿假单胞菌 IgG1 反应与肺功能下降。
Cell Rep Med. 2023 Oct 17;4(10):101210. doi: 10.1016/j.xcrm.2023.101210.
9
Mutation-class dependent signatures outweigh disease-associated processes in cystic fibrosis cells.在囊性纤维化细胞中,突变类别依赖性特征比疾病相关过程更为重要。
Cell Biosci. 2023 Feb 9;13(1):26. doi: 10.1186/s13578-023-00975-y.
10
The missing person in gene-environment interactions.基因-环境相互作用中缺失的因素。
Adv Genet (Hoboken). 2021 Mar 4;2(1):e10041. doi: 10.1002/ggn2.10041. eCollection 2021 Mar.
甘露糖结合凝集素缺乏对囊性纤维化病程的影响:综述和荟萃分析。
Glycobiology. 2011 Mar;21(3):271-82. doi: 10.1093/glycob/cwq161. Epub 2010 Nov 2.
4
Understanding the population structure of North American patients with cystic fibrosis.了解北美囊性纤维化患者的人口结构。
Clin Genet. 2011 Feb;79(2):136-46. doi: 10.1111/j.1399-0004.2010.01502.x.
5
Variants in FAM13A are associated with chronic obstructive pulmonary disease.FAM13A 中的变异与慢性阻塞性肺疾病有关。
Nat Genet. 2010 Mar;42(3):200-2. doi: 10.1038/ng.535. Epub 2010 Feb 21.
6
Disease gene characterization through large-scale co-expression analysis.通过大规模共表达分析进行疾病基因特征分析。
PLoS One. 2009 Dec 31;4(12):e8491. doi: 10.1371/journal.pone.0008491.
7
Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function.全基因组关联研究的荟萃分析确定了多个与肺功能相关的基因座。
Nat Genet. 2010 Jan;42(1):45-52. doi: 10.1038/ng.500. Epub 2009 Dec 13.
8
Genome-wide association study identifies five loci associated with lung function.全基因组关联研究鉴定出与肺功能相关的五个位点。
Nat Genet. 2010 Jan;42(1):36-44. doi: 10.1038/ng.501. Epub 2009 Dec 13.
9
CAS proteins in normal and pathological cell growth control.CAS 蛋白在正常和病理细胞生长调控中的作用。
Cell Mol Life Sci. 2010 Apr;67(7):1025-48. doi: 10.1007/s00018-009-0213-1. Epub 2009 Nov 25.
10
Energy intake and energy expenditure among children with polymorphisms of the melanocortin-3 receptor.黑素皮质素-3受体基因多态性儿童的能量摄入与能量消耗
Am J Clin Nutr. 2009 Oct;90(4):912-20. doi: 10.3945/ajcn.2009.27537. Epub 2009 Aug 5.